Fang EF, Hou Y, Lautrup S, Jensen MB, Yang B, SenGupta T, Caponio D, Khezri R, Demarest TG, Aman Y, Figueroa D, Morevati M, Lee HJ, Kato H, Kassahun H, Lee JH, Filippelli D, Okur MN, Mangerich A, Croteau DL, Maezawa Y, Lyssiotis CA, Tao J, Yokote K, Rusten TE, Mattson MP, Jasper H, Nilsen H, Bohr VA
Cagrilintide is in development as a monotherapy for the treatment of overweight and obesity and as a fixed-dose combination with the glucagon-like peptide-1 receptor agonist, semaglutide (CagriSema) for the treatment of overweight, obesity and type 2 diabetes
107 has shown that ubiquitination of H2BK34, which is surrounded by two coils of DNA superhelix, directly influences nucleosome conformation via steric hindrances
Numerous studies have reported the anti-diabetic effects of tea polyphenols in experimental diabetes models, demonstrating their ability to lower blood glucose levels, improve insulin sensitivity, and reduce oxidative stress and inflammation associated with type 2 diabetes mellitus (377, 378)
We combine L-carnitine with tartaric acid from grapes to create the robust L-carnitine tartrate